Sponsorizzato
Why is the 2026 focus on "sarcopenia detection" making bioimpedance the new standard of care for the aging population?
As the global population ages, the focus of 2026 healthcare has shifted toward "healthy aging" and the early detection of sarcopenia, or age-related muscle loss. This clinical need has become a major pillar of the bioimpedance analyzers market, as healthcare providers look for non-invasive ways to assess muscle quality and bone density in the elderly. Unlike traditional scans that involve...
0 Commenti 0 condivisioni 510 Views 0 Anteprima
Sponsorizzato
Sponsorizzato
Sponsorizzato